Comparison of cholesterol transport capacity of peptide- and polymer-based lipid Nanodiscs.

Apolipoprotein-based, synthetic high-density lipoprotein (sHDL) nanodiscs have been extensively studied as a potential therapeutic agent for cardiovascular disease due to their ability to promote reverse cholesterol transport. Recently, polymer-based nanodiscs have been made possible with the development of novel polymeric materials such as styrene-maleic anhydride copolymer (SMA). While the polymer-based nanodiscs resemble the discoidal structure of sHDLs, their functional similarity with sHDL has not been investigated. In the present study, we compared the SMA-based and peptide-based sHDL nanodiscs focusing on their cholesterol mobilization effects. Results showed that SMA-based nanoparticles presented similar particle size and in vitro cholesterol efflux effect to those of sHDL nanodiscs. However, SMA nanodiscs induced less cholesterol mobilization in vivo, possibly due to insufficient cholesterol esterification by lecithin:cholesterol acyltransferase.
Competing Interests: Conflict of interest Dr. Schwendeman declares financial interests for board membership, as a paid consultant, for research funding, and/or as equity holder in EVOQ Therapeutics. The University of Michigan has a financial interest in EVOQ Therapeutics, Inc.
(Copyright © 2024. Published by Elsevier Inc.)